Osaic Holdings
BLRX

Osaic Holdings’s BioLineRX BLRX Stock Holding History

Osaic Holdings’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81 Hold
26
– – ﹤0.01% 7849
2026
Q1 		$59 Hold
26
– – ﹤0.01% 7672
2025
Q4 		$71 Buy
26
+25
+2,500% +$86 ﹤0.01% 7668
2025
Q3 		$3 Hold
1
– – ﹤0.01% 7882
2025
Q2 		$4 Buy
+1
New +$4 ﹤0.01% 7710
2025
Q1 		– Sell
-30
Closed -$258 – 7462
2024
Q4 		$258 Hold
30
– – ﹤0.01% 7137
2024
Q3 		$646 Sell
30
-5
-14% -$137 ﹤0.01% 6962
2024
Q2 		$801 Buy
35
+5
+17% +$134 ﹤0.01% 6870
2024
Q1 		$1.35K Sell
30
-328
-92% -$16.5K ﹤0.01% 6608
2023
Q4 		$22.5K Sell
358
-247
-41% -$15.3K ﹤0.01% 5436
2023
Q3 		$44K Buy
605
+107
+21% +$7.19K ﹤0.01% 5077
2023
Q2 		$31.7K Sell
498
-276
-36% -$15.3K ﹤0.01% 5255
2023
Q1 		$27.4K Buy
774
+744
+2,480% +$19.6K ﹤0.01% 5373
2022
Q4 		$1K Sell
30
-236
-89% -$7.02K ﹤0.01% 6838
2022
Q3 		$10K Sell
266
-70
-21% -$3.99K ﹤0.01% 6001
2022
Q2 		$17K Sell
336
-128
-28% -$7.12K ﹤0.01% 5712
2022
Q1 		$31K Buy
464
+83
+22% +$5.78K ﹤0.01% 5415
2021
Q4 		$31K Buy
381
+196
+106% +$20.4K ﹤0.01% 5474
2021
Q3 		$20K Buy
185
+163
+741% +$19.3K ﹤0.01% 5761
2021
Q2 		$2K Hold
22
– – ﹤0.01% 6680
2021
Q1 		$2K Buy
22
+19
+633% +$2.29K ﹤0.01% 6464
2020
Q4 		$0 Hold
3
– – ﹤0.01% 6394
2020
Q3 		$0 Hold
3
– – ﹤0.01% 6203
2020
Q2 		$0 Hold
3
– – ﹤0.01% 6114
2020
Q1 		$0 Buy
+3
New +$238 ﹤0.01% 6059

Other funds holding BLRX

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
BCV
Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.21B AUM 33.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Osaic Holdings's BLRX Position: Q2 2026 in Review

Osaic Holdings held its BioLineRX (BLRX) position steady in Q2 2026 at 26 shares worth $81. The position accounts for ﹤0.01% of the portfolio, ranked #7849.

Osaic Holdings first reported a position in BLRX in Q1 2020 and has held it in 25 quarters since. The position peaked at $44K in Q3 2023. 14 funds tracked by Wall St. Rank hold BLRX as of Q2 2026.

  • Osaic Holdings held 26 shares of BioLineRX worth $81 as of Q2 2026.
  • Osaic Holdings left its BioLineRX share count unchanged in Q2 2026.
  • BioLineRX made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7849 holding.
  • Osaic Holdings first reported a position in BioLineRX in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's BioLineRX position peaked at $44K in Q3 2023.
  • 14 funds tracked by Wall St. Rank held BioLineRX as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.